Asbestos Research Today is a free monthly online journal that collates and summarizes the latest research about Asbestos, including details on mesothelioma, lung disease, dangers, effects, risks.

Malignant mesothelioma as both a challenge and an opportunity.

Mutti L, Broaddus VC

ASL 11, Laboratorio di Oncologia Clinica, Vercelli, Italy. ftepjm@tin.it

The International Mesothelioma Interest Group sponsored its 7th international meeting in Brescia, Italy from June 24-26, 2004. The meeting, entitled 'How advanced technology and new drugs are changing the perspectives of patients with malignant mesothelioma', was organized by Luciano Mutti (Vercelli, Italy) and GF Tassi (Brescia, Italy) and was attended by 350 participants. The general tone of the meeting was that real progress is now coming in the understanding of mesothelioma biology, progress that may soon translate into improved treatment options. The investigators and clinicians agreed on the importance of referring patients with mesothelioma to centers with expertise where patients can receive the best available treatments and can be offered entry into clinical trials of new and promising agents.

Published 13 December 2004 in Oncogene, 23(57): 9155-61.
Full-text of this article is available online (may require subscription).

© 2004-2008 Asbestos Research Today. All Rights Reserved.